Victory Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,792
| Closed | -$313K | – | 2610 |
|
|
2022
Q3 | $313K | Hold |
4,792
| – | – | ﹤0.01% | 2235 |
|
|
2022
Q2 | $291K | Hold |
4,792
| – | – | ﹤0.01% | 2245 |
|
|
2022
Q1 | $238K | Hold |
4,792
| – | – | ﹤0.01% | 2371 |
|
|
2021
Q4 | $363K | Sell |
4,792
-14,671
| -75% | -$1.11M | ﹤0.01% | 2316 |
|
|
2021
Q3 | $2.18M | Sell |
19,463
-2,919
| -13% | -$327K | ﹤0.01% | 1575 |
|
|
2021
Q2 | $3.62M | Sell |
22,382
-7,152
| -24% | -$1.16M | ﹤0.01% | 1451 |
|
|
2021
Q1 | $3.6M | Sell |
29,534
-8,088
| -21% | -$986K | ﹤0.01% | 1459 |
|
|
2020
Q4 | $5.76M | Buy |
37,622
+5,273
| +16% | +$807K | 0.01% | 1205 |
|
|
2020
Q3 | $2.71M | Buy |
32,349
+22,961
| +245% | +$1.92M | ﹤0.01% | 1356 |
|
|
2020
Q2 | $690K | Sell |
9,388
-9,388
| -50% | -$690K | ﹤0.01% | 1880 |
|
|
2020
Q1 | $796K | Buy |
18,776
+9,276
| +98% | +$393K | ﹤0.01% | 1932 |
|
|
2019
Q4 | $579K | Hold |
9,500
| – | – | ﹤0.01% | 1948 |
|
|
2019
Q3 | $389K | Buy |
+9,500
| New | +$389K | ﹤0.01% | 1981 |
|
|
2019
Q1 | – | Sell |
-37,620
| Closed | -$1.08M | – | 1800 |
|
|
2018
Q4 | $1.08M | Sell |
37,620
-640
| -2% | -$18.3K | ﹤0.01% | 1201 |
|
|
2018
Q3 | $1.7M | Sell |
38,260
-2,100
| -5% | -$93.1K | ﹤0.01% | 1130 |
|
|
2018
Q2 | $2.37M | Sell |
40,360
-2,310
| -5% | -$136K | 0.01% | 1042 |
|
|
2018
Q1 | $1.95M | Buy |
+42,670
| New | +$1.95M | ﹤0.01% | 1074 |
|